A case of Beh‡et's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab

被引：94
|
作者：
Hirano, Toru [1 ]
Ohguro, Nobuyuki [2 ]
Hohki, Satoshi [3 ]
Hagihara, Keisuke [1 ]
Shima, Yoshihito [1 ]
Narazaki, Masashi [1 ]
Ogata, Atsushi [1 ]
Yoshizaki, Kazuyuki [4 ]
Kumanogoh, Atsushi [1 ]
Kishimoto, Tadamitsu [5 ]
Tanaka, Toshio [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka 5650871, Japan
[2] Osaka Koseinenkin Hosp, Dept Ophthalmol, Osaka, Japan
[3] Toyama Univ, Dept Ophthalmol, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan
[4] Osaka Univ, Ctr Adv Sci & Innovat, Suita, Osaka 5650871, Japan
[5] Osaka Univ, Lab Immune Regulat, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan
来源：
MODERN RHEUMATOLOGY | 2012年 / 22卷 / 02期
关键词：
Behcet's disease; IL-6; Tocilizumab; GENOME-WIDE ASSOCIATION; BEHCETS-DISEASE; CEREBROSPINAL-FLUID; INTERLEUKIN-6; IL23R-IL12RB2; GENERATION; THERAPY; CELLS; IL10;
D O I：
10.1007/s10165-011-0497-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A 47-year-old female patient with Beh double dagger et's disease had been treated with colchicine, prednisolone, cyclosporine A, and infliximab. Because she relapsed, however, treatment with tocilizumab, a humanized anti-interleukin 6 receptor antibody, was started. This treatment suppressed the patient's clinical manifestations, including ocular attacks, for 1 year and improved her visual acuity. This experience indicates that tocilizumab may constitute a therapeutic option for refractory Beh double dagger et's disease.
引用
收藏
页码：298 / 302
页数：5
相关论文
共 50 条
  • [41] IL-6 Signaling and its Blockade with a Humanized Anti-Interleukin-6 Receptor Antibody in Rheumatoid Arthritis: Advent of a New and Innovative Therapeutic Drug, Tocilizumab
    Ohsugi, Yoshiyuki
    Kishimoto, Tadamitsu
    CURRENT RHEUMATOLOGY REVIEWS, 2011, 7 (04) : 288 - 300
  • [42] Uneventful splenectomy and cholecystectomy in a patient treated with anti-interleukin-6 receptor antibody therapy
    Ishizaki, Morihiko
    Sasada, Tetsuro
    Kunitomi, Akane
    Konaka, Yoshiteru
    Yagita, Masato
    Gunji, Shutaro
    Kanai, Michiyuki
    Nishimoto, Norihiro
    Takabayashi, Arimichi
    LANGENBECKS ARCHIVES OF SURGERY, 2008, 393 (03) : 423 - 425
  • [43] Uneventful splenectomy and cholecystectomy in a patient treated with anti-interleukin-6 receptor antibody therapy
    Morihiko Ishizaki
    Tetsuro Sasada
    Akane Kunitomi
    Yoshiteru Konaka
    Masato Yagita
    Shutaro Gunji
    Michiyuki Kanai
    Norihiro Nishimoto
    Arimichi Takabayashi
    Langenbeck's Archives of Surgery, 2008, 393 : 423 - 425
  • [44] Humanized anti-interleukin-6 receptor antibody (Tocilizumab) in monotherapy prevents the loss of lumbar and femoral bone mineral density in patients with early rheumatoid arthritis
    Hashimoto, J.
    Miyasaka, N.
    Yamamoto, K.
    Kawai, S.
    Takeuchi, T.
    Yoshikawa, H.
    Kishimotos, T.
    Nishimoto, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 320 - 320
  • [45] Lung transplantation for idiopathic multicentric Castleman disease: potential efficacy and tolerability of a humanized anti-interleukin-6 receptor monoclonal antibody
    Tomioka, Yasuaki
    Otani, Shinji
    Tanaka, Shin
    Shien, Kazuhiko
    Suzawa, Ken
    Miyoshi, Kentaroh
    Yamamoto, Hiromasa
    Okazaki, Mikio
    Sugimoto, Seiichiro
    Yamane, Masaomi
    Toyooka, Shinichi
    SURGICAL CASE REPORTS, 2021, 7 (01)
  • [46] Lung transplantation for idiopathic multicentric Castleman disease: potential efficacy and tolerability of a humanized anti-interleukin-6 receptor monoclonal antibody
    Yasuaki Tomioka
    Shinji Otani
    Shin Tanaka
    Kazuhiko Shien
    Ken Suzawa
    Kentaroh Miyoshi
    Hiromasa Yamamoto
    Mikio Okazaki
    Seiichiro Sugimoto
    Masaomi Yamane
    Shinichi Toyooka
    Surgical Case Reports, 7
  • [47] ANTI-INTERLEUKIN-6 (TOCILIZUMAB) EXPERIENCE IN TAKAYASU'S ARTERITIS PATIENTS
    Kilic, L.
    Karadag, O.
    Erden, A.
    Sari, A.
    Armagan, B.
    Firat, E.
    Kalyoncu, U.
    Bilgen, S. Apras
    Kiraz, S.
    Ertenli, I.
    Akdogan, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 437 - 438
  • [48] The therapy of autoimmune diseases by anti-interleukin-6 receptor antibody
    Mihara, M
    Nishimoto, N
    Ohsugi, Y
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (05) : 683 - 690
  • [49] The Effect of Anti-Interleukin-6 Receptor Antibody in Ovariectomized Mice
    Kato, Sho
    Wakabayashi, Hiroki
    Nakagawa, Taro
    Naito, Yohei
    Iino, Takahiro
    Sudo, Akihiro
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [50] A Humanized Anti-Interleukin 6 Receptor Monoclonal Antibody, Tocilizumab, for the Treatment of Endometriosis in a Rat Model
    Taskin, Mine Islimye
    Gungor, Aysenur Cakir
    Adali, Ertan
    Yay, Arzu
    Onder, Gozde Ozge
    Inceboz, Umit
    REPRODUCTIVE SCIENCES, 2016, 23 (05) : 662 - 669
12345